Global Needle-Free Drug Delivery Systems Market

Needle-Free Drug Delivery Systems Comprehensive Study by Type (Jet-based, Spring-based, Laser-based), Application (Pain management, Pediatric injections, Vaccine delivery, Oncology, Insulin delivery, Others), Technology (Trans-dermal Patch Technology, Inhaler Technology, Jet Injectors, Novel Needle Free Technologies), End User (Hospitals, Research Laboratories, Home Care Settings) Players and Region - Global Market Outlook to 2030

Needle-Free Drug Delivery Systems Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 12.5%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Needle-Free Drug Delivery Systems
Needle-free drug delivery system is used to drive medicines using any force such as shock waves and pressure of gas through the skin. This process is done without a needle. The devices used for needle-free drug delivery are reusable. There is various type of needle-free drug delivery system such as Jet-based, spring-based and laser-based. Insulin delivery was the most protuberant application of needle-free drug delivery system.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketAsia Pacific
UnitValue (USD Million)
CAGR12.5%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Needle-Free Drug Delivery Systems market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Antares Pharma (United States), Pharmajet (United States), Optinose (United States), Valeritas (United States), Crossject (France), Injex Pharma (Germany), 3M Pharmaceuticals (United States), Becton Dickinson (BD) (United States), MedImmune (United States), Mystic Pharmaceuticals (United States) and AkraDermojetInc (France) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Glide Pharmaceutical Technologies Ltd. (United Kingdom), Inovio Pharmaceuticals (United States) and Zogenix (United States).

Segmentation Overview
AMA Research has segmented the market of Global Needle-Free Drug Delivery Systems market by Type (Jet-based, Spring-based and Laser-based), Application (Pain management, Pediatric injections, Vaccine delivery, Oncology, Insulin delivery and Others) and Region.



On the basis of geography, the market of Needle-Free Drug Delivery Systems has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Technology, the sub-segment i.e. Trans-dermal Patch Technology will boost the Needle-Free Drug Delivery Systems market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Needle-Free Drug Delivery Systems market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Rising Number of Infectious Diseases and Introduction of Self-Inject able Drugs in Rheumatoid Arthritis

Market Growth Drivers:
Fueling Demand of Pain free Delivery and Increasing Demand of Self Administration of the Drug

Challenges:
High Development Costs

Restraints:
High Cost of Needle-Free Drug Delivery Systems

Opportunities:
Introduction of Technologically Advanced Products such as Insulin Micropump

Market Leaders and their expansionary development strategies
In May 2022, Zealand Pharma A/S entered into an asset purchase agreement with MannKind Corporation to sell the V-Go insulin delivery device for USD 10 million and additional sales-based milestones. V-Go is a once-daily, wearable, patch-like insulin delivery device that helps provide Source: https://www.mordorintelligence.com/industry-reports/needle-free-drug-delivery-devices-market
In October 2022, NuGen Medical Devices Inc. , a leader in needle-free drug delivery, is pleased to announce the official launch of its InsuJet™ devices in Canada. SOL-MILLENNIUM Medical Group (“Sol-Millennium” or “Sol-M”), a global healthcare company dedicated to the design, manufacturing, and distribution of high-quality medical devices and personal protective equipment


Key Target Audience
Needle free drug delivery system Providers, Needle free drug delivery Devices Manufactures, Needle free drug delivery Devices Suppliers, Health Care Organizations, Re sellers, Potential Investors, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Jet-based
  • Spring-based
  • Laser-based
By Application
  • Pain management
  • Pediatric injections
  • Vaccine delivery
  • Oncology
  • Insulin delivery
  • Others
By Technology
  • Trans-dermal Patch Technology
  • Inhaler Technology
  • Jet Injectors
  • Novel Needle Free Technologies

By End User
  • Hospitals
  • Research Laboratories
  • Home Care Settings

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Fueling Demand of Pain free Delivery
      • 3.2.2. Increasing Demand of Self Administration of the Drug
    • 3.3. Market Challenges
      • 3.3.1. High Development Costs
    • 3.4. Market Trends
      • 3.4.1. Rising Number of Infectious Diseases
      • 3.4.2. Introduction of Self-Inject able Drugs in Rheumatoid Arthritis
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Needle-Free Drug Delivery Systems, by Type, Application, Technology, End User and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Needle-Free Drug Delivery Systems (Value)
      • 5.2.1. Global Needle-Free Drug Delivery Systems by: Type (Value)
        • 5.2.1.1. Jet-based
        • 5.2.1.2. Spring-based
        • 5.2.1.3. Laser-based
      • 5.2.2. Global Needle-Free Drug Delivery Systems by: Application (Value)
        • 5.2.2.1. Pain management
        • 5.2.2.2. Pediatric injections
        • 5.2.2.3. Vaccine delivery
        • 5.2.2.4. Oncology
        • 5.2.2.5. Insulin delivery
        • 5.2.2.6. Others
      • 5.2.3. Global Needle-Free Drug Delivery Systems by: Technology (Value)
        • 5.2.3.1. Trans-dermal Patch Technology
        • 5.2.3.2. Inhaler Technology
        • 5.2.3.3. Jet Injectors
        • 5.2.3.4. Novel Needle Free Technologies
      • 5.2.4. Global Needle-Free Drug Delivery Systems by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Research Laboratories
        • 5.2.4.3. Home Care Settings
      • 5.2.5. Global Needle-Free Drug Delivery Systems Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Needle-Free Drug Delivery Systems (Volume)
      • 5.3.1. Global Needle-Free Drug Delivery Systems by: Type (Volume)
        • 5.3.1.1. Jet-based
        • 5.3.1.2. Spring-based
        • 5.3.1.3. Laser-based
      • 5.3.2. Global Needle-Free Drug Delivery Systems by: Application (Volume)
        • 5.3.2.1. Pain management
        • 5.3.2.2. Pediatric injections
        • 5.3.2.3. Vaccine delivery
        • 5.3.2.4. Oncology
        • 5.3.2.5. Insulin delivery
        • 5.3.2.6. Others
      • 5.3.3. Global Needle-Free Drug Delivery Systems by: Technology (Volume)
        • 5.3.3.1. Trans-dermal Patch Technology
        • 5.3.3.2. Inhaler Technology
        • 5.3.3.3. Jet Injectors
        • 5.3.3.4. Novel Needle Free Technologies
      • 5.3.4. Global Needle-Free Drug Delivery Systems by: End User (Volume)
        • 5.3.4.1. Hospitals
        • 5.3.4.2. Research Laboratories
        • 5.3.4.3. Home Care Settings
      • 5.3.5. Global Needle-Free Drug Delivery Systems Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Needle-Free Drug Delivery Systems (Price)
      • 5.4.1. Global Needle-Free Drug Delivery Systems by: Type (Price)
  • 6. Needle-Free Drug Delivery Systems: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Antares Pharma (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pharmajet (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Optinose (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Valeritas (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Crossject (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Injex Pharma (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. 3M Pharmaceuticals (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Becton Dickinson (BD) (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. MedImmune (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Mystic Pharmaceuticals (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. AkraDermojetInc (France)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Needle-Free Drug Delivery Systems Sale, by Type, Application, Technology, End User and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Needle-Free Drug Delivery Systems (Value)
      • 7.2.1. Global Needle-Free Drug Delivery Systems by: Type (Value)
        • 7.2.1.1. Jet-based
        • 7.2.1.2. Spring-based
        • 7.2.1.3. Laser-based
      • 7.2.2. Global Needle-Free Drug Delivery Systems by: Application (Value)
        • 7.2.2.1. Pain management
        • 7.2.2.2. Pediatric injections
        • 7.2.2.3. Vaccine delivery
        • 7.2.2.4. Oncology
        • 7.2.2.5. Insulin delivery
        • 7.2.2.6. Others
      • 7.2.3. Global Needle-Free Drug Delivery Systems by: Technology (Value)
        • 7.2.3.1. Trans-dermal Patch Technology
        • 7.2.3.2. Inhaler Technology
        • 7.2.3.3. Jet Injectors
        • 7.2.3.4. Novel Needle Free Technologies
      • 7.2.4. Global Needle-Free Drug Delivery Systems by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Research Laboratories
        • 7.2.4.3. Home Care Settings
      • 7.2.5. Global Needle-Free Drug Delivery Systems Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Needle-Free Drug Delivery Systems (Volume)
      • 7.3.1. Global Needle-Free Drug Delivery Systems by: Type (Volume)
        • 7.3.1.1. Jet-based
        • 7.3.1.2. Spring-based
        • 7.3.1.3. Laser-based
      • 7.3.2. Global Needle-Free Drug Delivery Systems by: Application (Volume)
        • 7.3.2.1. Pain management
        • 7.3.2.2. Pediatric injections
        • 7.3.2.3. Vaccine delivery
        • 7.3.2.4. Oncology
        • 7.3.2.5. Insulin delivery
        • 7.3.2.6. Others
      • 7.3.3. Global Needle-Free Drug Delivery Systems by: Technology (Volume)
        • 7.3.3.1. Trans-dermal Patch Technology
        • 7.3.3.2. Inhaler Technology
        • 7.3.3.3. Jet Injectors
        • 7.3.3.4. Novel Needle Free Technologies
      • 7.3.4. Global Needle-Free Drug Delivery Systems by: End User (Volume)
        • 7.3.4.1. Hospitals
        • 7.3.4.2. Research Laboratories
        • 7.3.4.3. Home Care Settings
      • 7.3.5. Global Needle-Free Drug Delivery Systems Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Needle-Free Drug Delivery Systems (Price)
      • 7.4.1. Global Needle-Free Drug Delivery Systems by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Needle-Free Drug Delivery Systems: by Type(USD Million)
  • Table 2. Needle-Free Drug Delivery Systems Jet-based , by Region USD Million (2018-2023)
  • Table 3. Needle-Free Drug Delivery Systems Spring-based , by Region USD Million (2018-2023)
  • Table 4. Needle-Free Drug Delivery Systems Laser-based , by Region USD Million (2018-2023)
  • Table 5. Needle-Free Drug Delivery Systems: by Application(USD Million)
  • Table 6. Needle-Free Drug Delivery Systems Pain management , by Region USD Million (2018-2023)
  • Table 7. Needle-Free Drug Delivery Systems Pediatric injections , by Region USD Million (2018-2023)
  • Table 8. Needle-Free Drug Delivery Systems Vaccine delivery , by Region USD Million (2018-2023)
  • Table 9. Needle-Free Drug Delivery Systems Oncology , by Region USD Million (2018-2023)
  • Table 10. Needle-Free Drug Delivery Systems Insulin delivery , by Region USD Million (2018-2023)
  • Table 11. Needle-Free Drug Delivery Systems Others , by Region USD Million (2018-2023)
  • Table 12. Needle-Free Drug Delivery Systems: by Technology(USD Million)
  • Table 13. Needle-Free Drug Delivery Systems Trans-dermal Patch Technology , by Region USD Million (2018-2023)
  • Table 14. Needle-Free Drug Delivery Systems Inhaler Technology , by Region USD Million (2018-2023)
  • Table 15. Needle-Free Drug Delivery Systems Jet Injectors , by Region USD Million (2018-2023)
  • Table 16. Needle-Free Drug Delivery Systems Novel Needle Free Technologies , by Region USD Million (2018-2023)
  • Table 17. Needle-Free Drug Delivery Systems: by End User(USD Million)
  • Table 18. Needle-Free Drug Delivery Systems Hospitals , by Region USD Million (2018-2023)
  • Table 19. Needle-Free Drug Delivery Systems Research Laboratories , by Region USD Million (2018-2023)
  • Table 20. Needle-Free Drug Delivery Systems Home Care Settings , by Region USD Million (2018-2023)
  • Table 21. South America Needle-Free Drug Delivery Systems, by Country USD Million (2018-2023)
  • Table 22. South America Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 23. South America Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 24. South America Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 25. South America Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 26. Brazil Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 27. Brazil Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 28. Brazil Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 29. Brazil Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 30. Argentina Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 31. Argentina Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 32. Argentina Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 33. Argentina Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 34. Rest of South America Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 35. Rest of South America Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 36. Rest of South America Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 37. Rest of South America Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 38. Asia Pacific Needle-Free Drug Delivery Systems, by Country USD Million (2018-2023)
  • Table 39. Asia Pacific Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 40. Asia Pacific Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 41. Asia Pacific Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 42. Asia Pacific Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 43. China Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 44. China Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 45. China Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 46. China Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 47. Japan Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 48. Japan Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 49. Japan Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 50. Japan Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 51. India Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 52. India Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 53. India Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 54. India Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 55. South Korea Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 56. South Korea Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 57. South Korea Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 58. South Korea Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 59. Taiwan Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 60. Taiwan Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 61. Taiwan Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 62. Taiwan Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 63. Australia Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 64. Australia Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 65. Australia Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 66. Australia Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 70. Rest of Asia-Pacific Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 71. Europe Needle-Free Drug Delivery Systems, by Country USD Million (2018-2023)
  • Table 72. Europe Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 73. Europe Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 74. Europe Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 75. Europe Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 76. Germany Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 77. Germany Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 78. Germany Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 79. Germany Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 80. France Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 81. France Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 82. France Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 83. France Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 84. Italy Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 85. Italy Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 86. Italy Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 87. Italy Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 88. United Kingdom Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 89. United Kingdom Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 90. United Kingdom Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 91. United Kingdom Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 92. Netherlands Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 93. Netherlands Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 94. Netherlands Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 95. Netherlands Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 96. Rest of Europe Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 97. Rest of Europe Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 98. Rest of Europe Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 99. Rest of Europe Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 100. MEA Needle-Free Drug Delivery Systems, by Country USD Million (2018-2023)
  • Table 101. MEA Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 102. MEA Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 103. MEA Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 104. MEA Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 105. Middle East Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 106. Middle East Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 107. Middle East Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 108. Middle East Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 109. Africa Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 110. Africa Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 111. Africa Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 112. Africa Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 113. North America Needle-Free Drug Delivery Systems, by Country USD Million (2018-2023)
  • Table 114. North America Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 115. North America Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 116. North America Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 117. North America Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 118. United States Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 119. United States Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 120. United States Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 121. United States Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 122. Canada Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 123. Canada Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 124. Canada Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 125. Canada Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 126. Mexico Needle-Free Drug Delivery Systems, by Type USD Million (2018-2023)
  • Table 127. Mexico Needle-Free Drug Delivery Systems, by Application USD Million (2018-2023)
  • Table 128. Mexico Needle-Free Drug Delivery Systems, by Technology USD Million (2018-2023)
  • Table 129. Mexico Needle-Free Drug Delivery Systems, by End User USD Million (2018-2023)
  • Table 130. Needle-Free Drug Delivery Systems Sales: by Type(K Units)
  • Table 131. Needle-Free Drug Delivery Systems Sales Jet-based , by Region K Units (2018-2023)
  • Table 132. Needle-Free Drug Delivery Systems Sales Spring-based , by Region K Units (2018-2023)
  • Table 133. Needle-Free Drug Delivery Systems Sales Laser-based , by Region K Units (2018-2023)
  • Table 134. Needle-Free Drug Delivery Systems Sales: by Application(K Units)
  • Table 135. Needle-Free Drug Delivery Systems Sales Pain management , by Region K Units (2018-2023)
  • Table 136. Needle-Free Drug Delivery Systems Sales Pediatric injections , by Region K Units (2018-2023)
  • Table 137. Needle-Free Drug Delivery Systems Sales Vaccine delivery , by Region K Units (2018-2023)
  • Table 138. Needle-Free Drug Delivery Systems Sales Oncology , by Region K Units (2018-2023)
  • Table 139. Needle-Free Drug Delivery Systems Sales Insulin delivery , by Region K Units (2018-2023)
  • Table 140. Needle-Free Drug Delivery Systems Sales Others , by Region K Units (2018-2023)
  • Table 141. Needle-Free Drug Delivery Systems Sales: by Technology(K Units)
  • Table 142. Needle-Free Drug Delivery Systems Sales Trans-dermal Patch Technology , by Region K Units (2018-2023)
  • Table 143. Needle-Free Drug Delivery Systems Sales Inhaler Technology , by Region K Units (2018-2023)
  • Table 144. Needle-Free Drug Delivery Systems Sales Jet Injectors , by Region K Units (2018-2023)
  • Table 145. Needle-Free Drug Delivery Systems Sales Novel Needle Free Technologies , by Region K Units (2018-2023)
  • Table 146. Needle-Free Drug Delivery Systems Sales: by End User(K Units)
  • Table 147. Needle-Free Drug Delivery Systems Sales Hospitals , by Region K Units (2018-2023)
  • Table 148. Needle-Free Drug Delivery Systems Sales Research Laboratories , by Region K Units (2018-2023)
  • Table 149. Needle-Free Drug Delivery Systems Sales Home Care Settings , by Region K Units (2018-2023)
  • Table 150. South America Needle-Free Drug Delivery Systems Sales, by Country K Units (2018-2023)
  • Table 151. South America Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 152. South America Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 153. South America Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 154. South America Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 155. Brazil Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 156. Brazil Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 157. Brazil Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 158. Brazil Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 159. Argentina Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 160. Argentina Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 161. Argentina Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 162. Argentina Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 163. Rest of South America Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 164. Rest of South America Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 165. Rest of South America Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 166. Rest of South America Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 167. Asia Pacific Needle-Free Drug Delivery Systems Sales, by Country K Units (2018-2023)
  • Table 168. Asia Pacific Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 169. Asia Pacific Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 170. Asia Pacific Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 171. Asia Pacific Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 172. China Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 173. China Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 174. China Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 175. China Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 176. Japan Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 177. Japan Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 178. Japan Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 179. Japan Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 180. India Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 181. India Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 182. India Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 183. India Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 184. South Korea Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 185. South Korea Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 186. South Korea Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 187. South Korea Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 188. Taiwan Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 189. Taiwan Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 190. Taiwan Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 191. Taiwan Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 192. Australia Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 193. Australia Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 194. Australia Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 195. Australia Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 196. Rest of Asia-Pacific Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 197. Rest of Asia-Pacific Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 198. Rest of Asia-Pacific Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 199. Rest of Asia-Pacific Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 200. Europe Needle-Free Drug Delivery Systems Sales, by Country K Units (2018-2023)
  • Table 201. Europe Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 202. Europe Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 203. Europe Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 204. Europe Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 205. Germany Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 206. Germany Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 207. Germany Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 208. Germany Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 209. France Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 210. France Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 211. France Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 212. France Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 213. Italy Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 214. Italy Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 215. Italy Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 216. Italy Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 217. United Kingdom Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 218. United Kingdom Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 219. United Kingdom Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 220. United Kingdom Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 221. Netherlands Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 222. Netherlands Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 223. Netherlands Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 224. Netherlands Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 225. Rest of Europe Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 226. Rest of Europe Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 227. Rest of Europe Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 228. Rest of Europe Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 229. MEA Needle-Free Drug Delivery Systems Sales, by Country K Units (2018-2023)
  • Table 230. MEA Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 231. MEA Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 232. MEA Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 233. MEA Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 234. Middle East Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 235. Middle East Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 236. Middle East Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 237. Middle East Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 238. Africa Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 239. Africa Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 240. Africa Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 241. Africa Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 242. North America Needle-Free Drug Delivery Systems Sales, by Country K Units (2018-2023)
  • Table 243. North America Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 244. North America Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 245. North America Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 246. North America Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 247. United States Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 248. United States Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 249. United States Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 250. United States Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 251. Canada Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 252. Canada Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 253. Canada Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 254. Canada Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 255. Mexico Needle-Free Drug Delivery Systems Sales, by Type K Units (2018-2023)
  • Table 256. Mexico Needle-Free Drug Delivery Systems Sales, by Application K Units (2018-2023)
  • Table 257. Mexico Needle-Free Drug Delivery Systems Sales, by Technology K Units (2018-2023)
  • Table 258. Mexico Needle-Free Drug Delivery Systems Sales, by End User K Units (2018-2023)
  • Table 259. Needle-Free Drug Delivery Systems: by Type(USD/Units)
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Company Basic Information, Sales Area and Its Competitors
  • Table 271. Needle-Free Drug Delivery Systems: by Type(USD Million)
  • Table 272. Needle-Free Drug Delivery Systems Jet-based , by Region USD Million (2025-2030)
  • Table 273. Needle-Free Drug Delivery Systems Spring-based , by Region USD Million (2025-2030)
  • Table 274. Needle-Free Drug Delivery Systems Laser-based , by Region USD Million (2025-2030)
  • Table 275. Needle-Free Drug Delivery Systems: by Application(USD Million)
  • Table 276. Needle-Free Drug Delivery Systems Pain management , by Region USD Million (2025-2030)
  • Table 277. Needle-Free Drug Delivery Systems Pediatric injections , by Region USD Million (2025-2030)
  • Table 278. Needle-Free Drug Delivery Systems Vaccine delivery , by Region USD Million (2025-2030)
  • Table 279. Needle-Free Drug Delivery Systems Oncology , by Region USD Million (2025-2030)
  • Table 280. Needle-Free Drug Delivery Systems Insulin delivery , by Region USD Million (2025-2030)
  • Table 281. Needle-Free Drug Delivery Systems Others , by Region USD Million (2025-2030)
  • Table 282. Needle-Free Drug Delivery Systems: by Technology(USD Million)
  • Table 283. Needle-Free Drug Delivery Systems Trans-dermal Patch Technology , by Region USD Million (2025-2030)
  • Table 284. Needle-Free Drug Delivery Systems Inhaler Technology , by Region USD Million (2025-2030)
  • Table 285. Needle-Free Drug Delivery Systems Jet Injectors , by Region USD Million (2025-2030)
  • Table 286. Needle-Free Drug Delivery Systems Novel Needle Free Technologies , by Region USD Million (2025-2030)
  • Table 287. Needle-Free Drug Delivery Systems: by End User(USD Million)
  • Table 288. Needle-Free Drug Delivery Systems Hospitals , by Region USD Million (2025-2030)
  • Table 289. Needle-Free Drug Delivery Systems Research Laboratories , by Region USD Million (2025-2030)
  • Table 290. Needle-Free Drug Delivery Systems Home Care Settings , by Region USD Million (2025-2030)
  • Table 291. South America Needle-Free Drug Delivery Systems, by Country USD Million (2025-2030)
  • Table 292. South America Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 293. South America Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 294. South America Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 295. South America Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 296. Brazil Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 297. Brazil Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 298. Brazil Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 299. Brazil Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 300. Argentina Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 301. Argentina Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 302. Argentina Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 303. Argentina Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 304. Rest of South America Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 305. Rest of South America Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 306. Rest of South America Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 307. Rest of South America Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 308. Asia Pacific Needle-Free Drug Delivery Systems, by Country USD Million (2025-2030)
  • Table 309. Asia Pacific Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 310. Asia Pacific Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 311. Asia Pacific Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 312. Asia Pacific Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 313. China Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 314. China Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 315. China Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 316. China Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 317. Japan Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 318. Japan Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 319. Japan Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 320. Japan Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 321. India Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 322. India Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 323. India Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 324. India Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 325. South Korea Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 326. South Korea Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 327. South Korea Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 328. South Korea Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 329. Taiwan Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 330. Taiwan Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 331. Taiwan Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 332. Taiwan Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 333. Australia Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 334. Australia Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 335. Australia Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 336. Australia Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 337. Rest of Asia-Pacific Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 338. Rest of Asia-Pacific Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 339. Rest of Asia-Pacific Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 340. Rest of Asia-Pacific Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 341. Europe Needle-Free Drug Delivery Systems, by Country USD Million (2025-2030)
  • Table 342. Europe Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 343. Europe Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 344. Europe Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 345. Europe Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 346. Germany Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 347. Germany Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 348. Germany Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 349. Germany Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 350. France Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 351. France Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 352. France Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 353. France Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 354. Italy Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 355. Italy Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 356. Italy Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 357. Italy Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 358. United Kingdom Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 359. United Kingdom Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 360. United Kingdom Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 361. United Kingdom Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 362. Netherlands Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 363. Netherlands Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 364. Netherlands Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 365. Netherlands Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 366. Rest of Europe Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 367. Rest of Europe Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 368. Rest of Europe Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 369. Rest of Europe Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 370. MEA Needle-Free Drug Delivery Systems, by Country USD Million (2025-2030)
  • Table 371. MEA Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 372. MEA Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 373. MEA Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 374. MEA Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 375. Middle East Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 376. Middle East Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 377. Middle East Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 378. Middle East Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 379. Africa Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 380. Africa Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 381. Africa Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 382. Africa Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 383. North America Needle-Free Drug Delivery Systems, by Country USD Million (2025-2030)
  • Table 384. North America Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 385. North America Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 386. North America Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 387. North America Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 388. United States Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 389. United States Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 390. United States Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 391. United States Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 392. Canada Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 393. Canada Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 394. Canada Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 395. Canada Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 396. Mexico Needle-Free Drug Delivery Systems, by Type USD Million (2025-2030)
  • Table 397. Mexico Needle-Free Drug Delivery Systems, by Application USD Million (2025-2030)
  • Table 398. Mexico Needle-Free Drug Delivery Systems, by Technology USD Million (2025-2030)
  • Table 399. Mexico Needle-Free Drug Delivery Systems, by End User USD Million (2025-2030)
  • Table 400. Needle-Free Drug Delivery Systems Sales: by Type(K Units)
  • Table 401. Needle-Free Drug Delivery Systems Sales Jet-based , by Region K Units (2025-2030)
  • Table 402. Needle-Free Drug Delivery Systems Sales Spring-based , by Region K Units (2025-2030)
  • Table 403. Needle-Free Drug Delivery Systems Sales Laser-based , by Region K Units (2025-2030)
  • Table 404. Needle-Free Drug Delivery Systems Sales: by Application(K Units)
  • Table 405. Needle-Free Drug Delivery Systems Sales Pain management , by Region K Units (2025-2030)
  • Table 406. Needle-Free Drug Delivery Systems Sales Pediatric injections , by Region K Units (2025-2030)
  • Table 407. Needle-Free Drug Delivery Systems Sales Vaccine delivery , by Region K Units (2025-2030)
  • Table 408. Needle-Free Drug Delivery Systems Sales Oncology , by Region K Units (2025-2030)
  • Table 409. Needle-Free Drug Delivery Systems Sales Insulin delivery , by Region K Units (2025-2030)
  • Table 410. Needle-Free Drug Delivery Systems Sales Others , by Region K Units (2025-2030)
  • Table 411. Needle-Free Drug Delivery Systems Sales: by Technology(K Units)
  • Table 412. Needle-Free Drug Delivery Systems Sales Trans-dermal Patch Technology , by Region K Units (2025-2030)
  • Table 413. Needle-Free Drug Delivery Systems Sales Inhaler Technology , by Region K Units (2025-2030)
  • Table 414. Needle-Free Drug Delivery Systems Sales Jet Injectors , by Region K Units (2025-2030)
  • Table 415. Needle-Free Drug Delivery Systems Sales Novel Needle Free Technologies , by Region K Units (2025-2030)
  • Table 416. Needle-Free Drug Delivery Systems Sales: by End User(K Units)
  • Table 417. Needle-Free Drug Delivery Systems Sales Hospitals , by Region K Units (2025-2030)
  • Table 418. Needle-Free Drug Delivery Systems Sales Research Laboratories , by Region K Units (2025-2030)
  • Table 419. Needle-Free Drug Delivery Systems Sales Home Care Settings , by Region K Units (2025-2030)
  • Table 420. South America Needle-Free Drug Delivery Systems Sales, by Country K Units (2025-2030)
  • Table 421. South America Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 422. South America Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 423. South America Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 424. South America Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 425. Brazil Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 426. Brazil Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 427. Brazil Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 428. Brazil Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 429. Argentina Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 430. Argentina Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 431. Argentina Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 432. Argentina Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 433. Rest of South America Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 434. Rest of South America Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 435. Rest of South America Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 436. Rest of South America Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 437. Asia Pacific Needle-Free Drug Delivery Systems Sales, by Country K Units (2025-2030)
  • Table 438. Asia Pacific Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 439. Asia Pacific Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 440. Asia Pacific Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 441. Asia Pacific Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 442. China Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 443. China Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 444. China Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 445. China Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 446. Japan Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 447. Japan Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 448. Japan Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 449. Japan Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 450. India Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 451. India Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 452. India Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 453. India Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 454. South Korea Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 455. South Korea Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 456. South Korea Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 457. South Korea Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 458. Taiwan Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 459. Taiwan Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 460. Taiwan Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 461. Taiwan Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 462. Australia Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 463. Australia Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 464. Australia Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 465. Australia Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 466. Rest of Asia-Pacific Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 467. Rest of Asia-Pacific Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 468. Rest of Asia-Pacific Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 469. Rest of Asia-Pacific Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 470. Europe Needle-Free Drug Delivery Systems Sales, by Country K Units (2025-2030)
  • Table 471. Europe Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 472. Europe Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 473. Europe Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 474. Europe Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 475. Germany Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 476. Germany Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 477. Germany Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 478. Germany Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 479. France Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 480. France Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 481. France Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 482. France Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 483. Italy Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 484. Italy Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 485. Italy Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 486. Italy Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 487. United Kingdom Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 488. United Kingdom Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 489. United Kingdom Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 490. United Kingdom Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 491. Netherlands Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 492. Netherlands Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 493. Netherlands Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 494. Netherlands Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 495. Rest of Europe Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 496. Rest of Europe Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 497. Rest of Europe Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 498. Rest of Europe Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 499. MEA Needle-Free Drug Delivery Systems Sales, by Country K Units (2025-2030)
  • Table 500. MEA Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 501. MEA Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 502. MEA Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 503. MEA Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 504. Middle East Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 505. Middle East Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 506. Middle East Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 507. Middle East Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 508. Africa Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 509. Africa Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 510. Africa Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 511. Africa Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 512. North America Needle-Free Drug Delivery Systems Sales, by Country K Units (2025-2030)
  • Table 513. North America Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 514. North America Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 515. North America Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 516. North America Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 517. United States Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 518. United States Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 519. United States Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 520. United States Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 521. Canada Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 522. Canada Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 523. Canada Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 524. Canada Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 525. Mexico Needle-Free Drug Delivery Systems Sales, by Type K Units (2025-2030)
  • Table 526. Mexico Needle-Free Drug Delivery Systems Sales, by Application K Units (2025-2030)
  • Table 527. Mexico Needle-Free Drug Delivery Systems Sales, by Technology K Units (2025-2030)
  • Table 528. Mexico Needle-Free Drug Delivery Systems Sales, by End User K Units (2025-2030)
  • Table 529. Needle-Free Drug Delivery Systems: by Type(USD/Units)
  • Table 530. Research Programs/Design for This Report
  • Table 531. Key Data Information from Secondary Sources
  • Table 532. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Needle-Free Drug Delivery Systems: by Type USD Million (2018-2023)
  • Figure 5. Global Needle-Free Drug Delivery Systems: by Application USD Million (2018-2023)
  • Figure 6. Global Needle-Free Drug Delivery Systems: by Technology USD Million (2018-2023)
  • Figure 7. Global Needle-Free Drug Delivery Systems: by End User USD Million (2018-2023)
  • Figure 8. South America Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 9. Asia Pacific Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 10. Europe Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 11. MEA Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 12. North America Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 13. Global Needle-Free Drug Delivery Systems: by Type K Units (2018-2023)
  • Figure 14. Global Needle-Free Drug Delivery Systems: by Application K Units (2018-2023)
  • Figure 15. Global Needle-Free Drug Delivery Systems: by Technology K Units (2018-2023)
  • Figure 16. Global Needle-Free Drug Delivery Systems: by End User K Units (2018-2023)
  • Figure 17. South America Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 18. Asia Pacific Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 19. Europe Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 20. MEA Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 21. North America Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 22. Global Needle-Free Drug Delivery Systems: by Type USD/Units (2018-2023)
  • Figure 23. Global Needle-Free Drug Delivery Systems share by Players 2023 (%)
  • Figure 24. Global Needle-Free Drug Delivery Systems share by Players (Top 3) 2023(%)
  • Figure 25. Global Needle-Free Drug Delivery Systems share by Players (Top 5) 2023(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Antares Pharma (United States) Revenue, Net Income and Gross profit
  • Figure 28. Antares Pharma (United States) Revenue: by Geography 2023
  • Figure 29. Pharmajet (United States) Revenue, Net Income and Gross profit
  • Figure 30. Pharmajet (United States) Revenue: by Geography 2023
  • Figure 31. Optinose (United States) Revenue, Net Income and Gross profit
  • Figure 32. Optinose (United States) Revenue: by Geography 2023
  • Figure 33. Valeritas (United States) Revenue, Net Income and Gross profit
  • Figure 34. Valeritas (United States) Revenue: by Geography 2023
  • Figure 35. Crossject (France) Revenue, Net Income and Gross profit
  • Figure 36. Crossject (France) Revenue: by Geography 2023
  • Figure 37. Injex Pharma (Germany) Revenue, Net Income and Gross profit
  • Figure 38. Injex Pharma (Germany) Revenue: by Geography 2023
  • Figure 39. 3M Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 40. 3M Pharmaceuticals (United States) Revenue: by Geography 2023
  • Figure 41. Becton Dickinson (BD) (United States) Revenue, Net Income and Gross profit
  • Figure 42. Becton Dickinson (BD) (United States) Revenue: by Geography 2023
  • Figure 43. MedImmune (United States) Revenue, Net Income and Gross profit
  • Figure 44. MedImmune (United States) Revenue: by Geography 2023
  • Figure 45. Mystic Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 46. Mystic Pharmaceuticals (United States) Revenue: by Geography 2023
  • Figure 47. AkraDermojetInc (France) Revenue, Net Income and Gross profit
  • Figure 48. AkraDermojetInc (France) Revenue: by Geography 2023
  • Figure 49. Global Needle-Free Drug Delivery Systems: by Type USD Million (2025-2030)
  • Figure 50. Global Needle-Free Drug Delivery Systems: by Application USD Million (2025-2030)
  • Figure 51. Global Needle-Free Drug Delivery Systems: by Technology USD Million (2025-2030)
  • Figure 52. Global Needle-Free Drug Delivery Systems: by End User USD Million (2025-2030)
  • Figure 53. South America Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 54. Asia Pacific Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 55. Europe Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 56. MEA Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 57. North America Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 58. Global Needle-Free Drug Delivery Systems: by Type K Units (2025-2030)
  • Figure 59. Global Needle-Free Drug Delivery Systems: by Application K Units (2025-2030)
  • Figure 60. Global Needle-Free Drug Delivery Systems: by Technology K Units (2025-2030)
  • Figure 61. Global Needle-Free Drug Delivery Systems: by End User K Units (2025-2030)
  • Figure 62. South America Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 63. Asia Pacific Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 64. Europe Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 65. MEA Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 66. North America Needle-Free Drug Delivery Systems Share (%), by Country
  • Figure 67. Global Needle-Free Drug Delivery Systems: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Antares Pharma (United States)
  • Pharmajet (United States)
  • Optinose (United States)
  • Valeritas (United States)
  • Crossject (France)
  • Injex Pharma (Germany)
  • 3M Pharmaceuticals (United States)
  • Becton Dickinson (BD) (United States)
  • MedImmune (United States)
  • Mystic Pharmaceuticals (United States)
  • AkraDermojetInc (France)
Additional players considered in the study are as follows:
Glide Pharmaceutical Technologies Ltd. (United Kingdom) , Inovio Pharmaceuticals (United States) , Zogenix (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 246 Pages 81 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Needle-Free Drug Delivery Systems Market Quantitative research analysis
Global Needle-Free Drug Delivery Systems Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Antares Pharma (United States), Pharmajet (United States), Optinose (United States), Valeritas (United States), Crossject (France), Injex Pharma (Germany), 3M Pharmaceuticals (United States), Becton Dickinson (BD) (United States), MedImmune (United States), Mystic Pharmaceuticals (United States) and AkraDermojetInc (France) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Rising Number of Infectious Diseases " is seen as one of major influencing trends for Needle-Free Drug Delivery Systems Market during projected period 2023-2030.
The Needle-Free Drug Delivery Systems market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Needle-Free Drug Delivery Systems Market Report?

Have a Query? Click Here

Other Related Reports

Umbilical Cord Clamp Comprehensive Study by Type (Disposable, Reusable), Application (Hospitals, Clinics, Other), Distribution Channel (Offline, Online) Players and Region - Global Market Outlook to ...
$ 3500
Radiotherapy Device Comprehensive Study by Type (External Beam Radiotherapy Devices, Internal Beam Radiotherapy Devices), Application (Hospitals, Ambulatory Surgical Centres, Oncological Treatment Ce...
$ 3500
Portable Medical Devices Comprehensive Study by Type (Respiratory Monitoring Systems, Digital Hearing Aid, Insulin Pumps, Medical Imaging, Cardiac Monitor Systems, Fitness & Wellness, Independent Agi...
$ 3650
Vaccine Adjuvants Comprehensive Study by Type (Pathogen, Adjuvant Emulsion, Particulate, Combination, Others), Application (Veterinary Vaccine Adjuvants, Human Vaccine Adjuvants), Route of Administra...
$ 3650
Smart Medical Devices Comprehensive Study by Type (On-Body (Adhesive Patch), Off-Body (Belt Clip), Hand-Held), Application (Oncology, Diabetes, Auto-Immune Disorders, Infectious Diseases, Others), Di...
$ 3750
Pacemaker Devices Comprehensive Study by Type (Single Chamber Pacemaker, Dual Chamber Pacemaker, Biventricular Pacemaker), Application (Arrhythmia, Atrial Fibrillation, Bradycardia, Tachycardia), Tec...
$ 3650